Novo CEO pressed by Senate to cut charges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the corporate would take into account new talks with insurers in regards to the record costs of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Elevance lowers https://dantevmcsj.blogripley.com/31239136/healthcare-news-things-to-know-before-you-buy